You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.

Open menu


EU secures 300 million doses of BioNTech, Pfizer’s COVID-19 vaccine

The European Commission has secured a supply deal with BioNTech and Pfizer for 300 million doses of their COVID-19 vaccine candidate.